Are both baseline HIV-1 drug resistance and antiretroviral drug levels associated with short-term virologic responses to salvage therapy?
In salvage therapy, both the number of active drugs and the DL for each drug in the new regimen determine the antiviral response.
The results of the present study show that the dNLR has similar prognostic value to the NLR. Therefore, the universally available dNLR is to be commended for use in the risk stratification of patients undergoing chemotherapy.